Published in J Cell Physiol on December 01, 2008
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene (2009) 2.49
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer (2010) 1.77
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med (2009) 1.48
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res (2011) 1.18
GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda) (2009) 1.14
Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One (2011) 1.14
Targeted drug delivery in pancreatic cancer. Biochim Biophys Acta (2009) 0.92
Sry-box (Sox) transcription factors in gastrointestinal physiology and disease. Am J Physiol Gastrointest Liver Physiol (2011) 0.89
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol (2010) 0.86
Intestinal tumor in a dish. Front Med (Lausanne) (2014) 0.79
Role of stromal-epithelial interaction in the formation and development of cancer cells. Cancer Microenviron (2013) 0.76
CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Oncol Rep (2015) 0.76
The unbearable lightness of understanding clinical influence of lymph node micrometastasis. Langenbecks Arch Surg (2008) 0.75
The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1. Oncotarget (2017) 0.75